India Board Terminal · Specialisation hub
Healthcare & Life Sciences — mandates by specialisation
Clinical, pharmaceutical and medtech mandates — from care delivery to drug development.
- Open mandates
- 162 of 3,088 on the Terminal
- Specialisations
- 4 counted separately below
- Markets
- 29 countries hiring right now
- Urgent
- 89 briefed as urgent, not planned
The specialisations inside this hub
Chief Executives, Chief Medical and Chief Operating Officers, and the Commercial and Scientific Leadership across hospitals, pharmaceuticals and medical technology. The Sub-Groups below separate the healthcare careers that are different jobs within Healthcare: running care delivery and hospital networks, leading pharmaceutical and biotech pipelines, building medical device and diagnostics businesses, and owning patient access and health data.
49
Medical Devices & Diagnostics
Implantable devices, surgical systems, diagnostic services and the mandates that bring medtech to market.
27
Care Delivery & Hospitals
Hospital networks, clinical transformation, oncology networks and the mandates that run integrated care.
27
Pharmaceuticals & Biotech
Specialty pharma, cell therapy, clinical development and the mandates that own drug pipelines and commercial launch.
14
Patient Access & Data
Patient access organisations, clinical data platforms and the mandates that connect care to outcomes.
A mandate may sit in more than one specialisation, and frequently does — a finance chief running a carve-out is both an M&A seat and a controllership seat — so these counts sum to more than the hub. That is the corpus being honest rather than the arithmetic being wrong: filing each seat under exactly one discipline would mean choosing for the reader which half of the job matters.
What a free account opens, and what Foresight adds
Reading is free here, and that is not a trial — every one of these 162 briefs opens in full without paying. What a membership buys is the ability to act on them at volume, to reach the ones outside India, and to be found by them while you are working.
| Capability | Free accountFreeNo card, ever | Foresight India$600 a year₹52,200 all in, GST inside | Most members hereForesight Global$800 a year₹69,600 all in, GST inside |
|---|---|---|---|
| Read every brief in fullScope, reporting line, pay range, and the reason the seat is open. | All 162 | All 162 | All 162 |
| Markets you can read | India and international | India and international | India and international |
| Seats you can pursueReading is open to everyone. Acting is what a membership buys. | 38 — India only | 38 — India only | All 162, across 29 markets |
| Pursuits of your ownApplications you send yourself, on seats you choose. | One a week · 52 a year | 2 a day · 730 a year | 5 a day · 1,825 a year |
| The Whisper agentReads every new mandate against your record around the clock, and reaches you first. | Not included | Around the clock | Around the clock, every market |
| Foresight pursuitsWe propose the seat, write the portfolio for that board, and present you. | Not included | 6 a quarter | 8 a quarter |
| Your career map | The first move only | In full, across India | In full, across the major international markets |
| Career, Compensation & Global Mobility Strategy | Not included | Domestic edition | Every market your map reaches |
| Your name reaches a boardOn every tier, only when you approve that specific seat. | Only on your say-so | Only on your say-so | Only on your say-so |
| Create a free account | See Foresight India | See Foresight Global |
Counted against the 162 open healthcare & life sciences mandates on this page — 38 in India, 124 elsewhere. Prices are annual and all-inclusive, with GST already inside the figure shown; quarterly terms exist at a smaller allowance. Nothing on this page is behind any of them.
Why these seats are open
89
of 162 are briefed as urgent — an incumbent already gone, or going
- Planned Hiring / New66
- Urgent / Replacement42
- Urgent / Unplanned25
- Urgent / New22
- Planned Replacement7
Every mandate on the Terminal is filed with the reason it exists, which is the column no job board carries. An urgent seat is filled in weeks and is lost to timing; a planned one is briefed quietly months ahead and is lost to invisibility. The two reward opposite behaviours, and neither rewards checking a page once a week.
Closing soonest
94 of these mandates carry a published deadline, and 0 of those fall inside the next fortnight.
- Mon, 26 Oct29 daysGroup Chief Financial Officer — Diagnostic-Instruments BusinessGalway, Ireland · Medical Devices · permanent
- Mon, 26 Oct29 daysChief Technology Officer — Commercial Launch OrganisationDublin, Ireland · Pharmaceuticals · permanent
- Mon, 26 Oct29 daysChief Growth and Network Officer — Interim, Diagnostic ServicesBengaluru, India · Diagnostic Services · interim
- Mon, 26 Oct29 daysSenior Partner – Transformation — Clinical Data OrganisationZurich, Switzerland · Biotechnology · advisory
- Mon, 26 Oct29 daysDirector of Product Industrialisation — Interim, Surgical RoboticsPune, India · Surgical Robotics · interim
- Mon, 26 Oct29 daysDirector of Hospital Integration — Interim, Healthcare ServicesPune, India · Healthcare Services · interim
Where these mandates are
- India38
- United States30
- Switzerland22
- Singapore15
- Ireland14
- Australia6
- Germany6
- Denmark3
- Sweden3
- Canada2
- Saudi Arabia2
- Netherlands2
38 sit in India and 124 elsewhere, across 29 countries. Markets with a page of their own are linked; the rest are counted here and reachable through the directory.
Who you would report to
The most revealing line on a brief, and the one candidates most often skip. 96 distinct reporting lines appear across these mandates.
- Group Chief Executive or designated executive-committee sponsor42
- Global Managing Partner and regional partner council11
- Group Chief Executive and the relevant board committee10
- Group board and Group Chief Executive7
Lines named on fewer than four mandates are not shown — the tail is long by design, because a real board writes the structure it has rather than choosing from a menu.
How these seats are engaged
- permanent62
- interim44
- advisory30
- consulting26
By work mode: 89 onsite · 63 hybrid · 10 remote.
And the experience they ask for
- 22–28 years99
- 18–22 years31
- 28+ years28
Where these mandates come from
- Jobs Directly Posted by Firms113
- Jobs Posted by Fellow Members21
- Jobs Posted by NRCs / Boards17
- Direct Mandates of Gladwin International11
Nothing here was scraped. No row was lifted from another site, aggregated from a careers page or bought from a feed — which matters more than it sounds, because an aggregated corpus is how a candidate ends up applying to a seat that closed in March through a firm that never held the mandate. Every brief has a named person behind it who can answer a question about it.
What these seats pay
1 of 162
mandates here state a readable rupee range. Too few to take an honest median from — so this page does not print one.
The Terminal takes pay from the mandates themselves — the ranges boards actually briefed, not a survey of what people say they earn. That makes the figures honest and it makes them uneven, and where the sample is too thin to support a median this page shows none. A pay figure derived from one or two seats is that seat wearing the authority of a statistic.
Upload your profile to see what each market pays you →Open mandates in this hub
20 of 162. Title, market and engagement are open to everyone; the brief itself opens with a free account.
- Regional Vice President, Finance — Medical Device LifecycleMumbai, India · Medical Devices · permanent
- Chief Financial Officer — MedTech Commerce Channel and Service CapitalMumbai, India · Medical Technology Commerce · permanent
- Pharma Capital-Markets Accounting-Judgement AdviserHyderabad, India · Pharmaceuticals · advisory
- Pharma Transaction and IPO Financial-Evidence ConsultantHyderabad, India · Pharmaceuticals · consulting
- Health and Education Technology Long-Range Planning Design LeadMumbai, India · Health and Education Technology · consulting
- Vice President, Global Financial Control — Pharma BridgeHyderabad, India · Pharmaceuticals · interim
- Cell-and-Gene Patient-Custody Board ChallengerBoston, United States · Personalised Cell and Gene Therapies · advisory
- Digital-Therapeutic Governance Board AdviserStockholm, Sweden · Digital Therapeutics · advisory
- Named-Patient Medicine Supply Recovery LeaderDublin, Ireland · Rare-Disease Biotechnology · interim
- Life-Sciences 4PL Decision-Rights Board Examiner — Patient SupplyBasel, Switzerland · Life-Sciences Supply Networks · advisory
- Operating-Covenant Diagnostic DirectorDubai, United Arab Emirates · Integrated Airport Services · consulting
- Store-and-Forward Diagnostic Edge Assurance DirectorNairobi, Kenya · Distributed Telehealth Diagnostics · consulting
- Edge-AI Diagnostics Deployment LeaderNairobi, Kenya · Distributed Point-of-Care Diagnostics · interim
- Analogue Mixed-Signal Tape-Out Recovery Leader — Implantable DevicesDublin, Ireland · Implantable Medical Devices · interim
- Director of Environment, Health and Safety — Interim, ChemicalsMumbai, India · Chemical Manufacturing · interim
- Revenue Cycle Improvement Director — Consulting, Hospital NetworkHyderabad, India · Hospitals and Healthcare · consulting
- Autonomous-Assay Orchestration Recovery Authority — Drug DiscoveryBengaluru, India · Small-Molecule Drug Discovery · interim
- Clinical-AI Model Stewardship GCC Blueprint DirectorHyderabad, India · Global Clinical Development · consulting
- Contract Manufacturing Dependency Board Challenger — Consumer HealthCopenhagen, Denmark · Consumer Health Products · advisory
- Multimodal Clinical Triage Reliability LeaderLondon, United Kingdom · Virtual Urgent Care · interim
162 open. 89 urgent.
Reading costs nothing and always will. What a membership buys is the agent that watches while you work, the throughput to act on what it finds, and the right to pursue the seats outside India as well as read them.